search
Back to results

Efficacy of Structured Insulin Order

Primary Purpose

Type 2 Diabetes Mellitus

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Diabetes Management
Sponsored by
Massachusetts General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 2 Diabetes Mellitus focused on measuring type 2 diabetes mellitus, basal-bolus insulin, insulin ordering

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Blood glucose less than 60 mg/dl or greater than 180 mg/dl during hospital stay

Exclusion Criteria:

  • Diagnosis of Type 1 Diabetes

Sites / Locations

  • Massachusetts General Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Ordering template and education

Education

Arm Description

Internal medical residents who were asked to use the insulin order template and received education about basal-bolus insulin ordering.

Internal medical residents who received education about basal-bolus insulin ordering.

Outcomes

Primary Outcome Measures

Mean blood Glucose

Secondary Outcome Measures

rates of glucose values less than 60 mg/dl or less than 40 mg/dl
rate of use of sliding scale insulin

Full Information

First Posted
May 24, 2010
Last Updated
May 24, 2010
Sponsor
Massachusetts General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01130558
Brief Title
Efficacy of Structured Insulin Order
Official Title
Efficacy of Structured Insulin Orders in Improving Glycemic Control
Study Type
Interventional

2. Study Status

Record Verification Date
May 2010
Overall Recruitment Status
Completed
Study Start Date
March 2009 (undefined)
Primary Completion Date
June 2009 (Actual)
Study Completion Date
June 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Massachusetts General Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether an electronic order template for basal-bolus insulin will improve mean blood glucose in hospitalized general medical patients with poorly controlled type 2 diabetes.
Detailed Description
The study randomly assigned internal medicine residents to use an electronic insulin order template plus basal-bolus ordering education versus education only. For all patients with uncontrolled type 2 diabetes treated by these physicians, mean blood glucose, rate of hypoglycemia, and rate of sliding scale insulin use were measured.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes Mellitus
Keywords
type 2 diabetes mellitus, basal-bolus insulin, insulin ordering

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
128 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Ordering template and education
Arm Type
Active Comparator
Arm Description
Internal medical residents who were asked to use the insulin order template and received education about basal-bolus insulin ordering.
Arm Title
Education
Arm Type
Active Comparator
Arm Description
Internal medical residents who received education about basal-bolus insulin ordering.
Intervention Type
Other
Intervention Name(s)
Diabetes Management
Intervention Description
Using electronic insulin order template for basal-bolus insulin and education
Primary Outcome Measure Information:
Title
Mean blood Glucose
Time Frame
6 days
Secondary Outcome Measure Information:
Title
rates of glucose values less than 60 mg/dl or less than 40 mg/dl
Time Frame
6 days
Title
rate of use of sliding scale insulin
Time Frame
6 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Blood glucose less than 60 mg/dl or greater than 180 mg/dl during hospital stay Exclusion Criteria: Diagnosis of Type 1 Diabetes
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Enrico Cagliero, M.D.
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Massachusetts General Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Efficacy of Structured Insulin Order

We'll reach out to this number within 24 hrs